Patents
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
08/2007
08/15/2007EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
08/15/2007EP1817305A2 Compounds for the treatment of cns and amyloid associated diseases
08/15/2007EP1817301A1 Potentiators of glutamate receptors
08/15/2007EP1817300A1 Potentiators of glutamate receptors
08/15/2007EP1817297A1 Dibenzyl amine compounds and derivatives
08/15/2007EP1817296A1 Potentiators of glutamate receptors
08/15/2007EP1322596B1 Zwitterionic tachykinin receptor antagonists
08/15/2007CN1331866C Method for continuous extracting chlorophyll from silkworm dropping
08/15/2007CN1331862C Di-aryl acid derivatives as PPAR receptor ligands
08/15/2007CN101016269A Purifying process for novel tetranitroazole derivative
08/14/2007US7256287 small molecule inhibitors of the IgE response to allergens that are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic
08/09/2007WO2007088558A2 A process for purification of valsartan
08/08/2007EP1742926B1 Macrocycle-substituted trimer halogen-benzol derivatives
08/07/2007US7253288 Reacting aminotetrazole, nitrous acid, and a nucleophilic substitution compound having a NO2-, CN-, azido, or halogen anion in a chamber that has a channel cross-sectional diameter of less than one millimeter forming a substituted tetrazole
08/07/2007US7253199 Azole derivatives and pharmaceutical compositions containing them
08/07/2007US7253194 Compounds and inhibitors of phospholipases
08/02/2007WO2007085349A1 Process for preparing iodinated azoles
08/02/2007WO2007063702A3 Iminopropene compound and use thereof
08/02/2007WO2007017469A3 Process for preparing an angiotensin ii receptor antagonist
08/02/2007US20070179192 Thrombopoietin mimetics
08/01/2007EP1813607A2 Tetraaza- or N2S2- complexants, and their use in radiodiagnostics or radiotherapy
08/01/2007EP1813605A1 Method for preparing 2-alkoxy-5-tetrazolyl-benzaldehyde compound
08/01/2007EP1812411A2 Process for preparing valsartan
08/01/2007EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
07/2007
07/31/2007US7250433 Calcium channel blockers; central nervous system disorders; antiarthritic agents
07/26/2007WO2007083538A1 Epoxy bleedout-preventing agent
07/26/2007WO2007032019B1 Process for preparing valsartan
07/26/2007DE102006003444A1 Verfahren zur Herstellung von iodierten Azolen Process for the preparation of iodinated azoles
07/25/2007EP1809613A2 Methods of making 2,6-diaryl piperidine derivatives
07/25/2007EP1809299A2 Phosphonate substituted kinase inhibitors
07/25/2007EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
07/25/2007EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands
07/25/2007CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
07/25/2007CN101006064A Method for preparing irbesartan and intermediates thereof
07/24/2007US7247756 1,4-disubstituted benzenes as insecticides
07/19/2007WO2006138660A3 Sphingosine kinase inhibitors
07/19/2007US20070167655 Method for the production of tetrahydrogeranylacetone
07/19/2007US20070167635 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders
07/19/2007US20070167490 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
07/19/2007US20070167481 Imidazonaphthyridines
07/17/2007US7244851 1-[2-Cyclohexyl-2-(2-methylamino-propionylamino)-acetyl]-pyrrolidine-2-carboxylic acid (2-phenyl-2H-pyrazol-3-yl)-amide; inhibitors of IAP, for treating malignancies
07/12/2007US20070161801 Process for preparing substituted tetrazoles from aminotetrazole
07/12/2007US20070161691 Modified-protein formation inhibitor
07/12/2007US20070157845 Containing an optionally substituted bis(1H-tetrazole), e.g., 5,5'-bi(1H-tetrazole); 5,5'-azobis(mercaptotetrazole); and 5,5'-dithiobis(1-chlorotetrazole); improved heat resistance, adhesion to resin and solder wettability
07/11/2007EP1806350A2 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
07/11/2007EP1805158A1 Sulfonyl-substituted bicyclic compounds as modulators of ppar
07/11/2007EP1805152A2 Insecticidal 3-(dihaloalkenyl) phenyl derivatives
07/11/2007CN1997776A Additive for copper plating and process for producing electronic circuit substrate therewith
07/10/2007US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
07/05/2007WO2007074213A1 Macrocyclic oligonucleotide labeling reactants and conjugates derived thereof
07/05/2007US20070155725 N-(1-Aza-bicyclo[2.2.2]oct-3-yl)-5-cyano-2-(3,5-dichloro-phenoxy)-benzenesulfonamide; asthma, allergic rhinitis or lung granuloma, HIV; CC type chemokine receptor antagonist
07/05/2007US20070155704 t-Butyl 1-[9-[1-(tert-butoxycarbonyl)cyclopropyl]-5-oxononyl]-1-cyclopropanecarboxylate; Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, impotence
07/05/2007US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction
07/04/2007EP1802297A2 Compositions and methods for treatment of disease caused by yersinia spp infection
07/04/2007EP1301492B1 Novel tetrazole derivatives
07/04/2007CN1993357A Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
07/04/2007CN1993335A Indanone potentiators of metabotropic glutamate receptors
07/04/2007CN1993049A 5-iodotetrazoles
07/04/2007CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
07/03/2007US7238714 Analgesics; antiinflammatory agents; antiarthritic agents
07/03/2007US7238679 novel family of quinazolines (and pharmaceutically acceptable derivatives thereof that have a range of useful biological and pharmacological properties
06/2007
06/28/2007WO2007071750A1 Intermediates and processes for the preparation of valsartan
06/28/2007WO2007044724A3 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3
06/28/2007US20070149615 Ketone compounds and compositions for cholesterol management and related uses
06/28/2007US20070149587 Valsartan Salts
06/27/2007EP1263738B1 Substituted benzoylcyclohexenones
06/21/2007WO2007069684A1 Phthalamide derivative, agricultural or horticultural pesticide, and use of the pesticide
06/21/2007WO2007047447A3 Diuretic-like compound analogs useful for regulation of central nervous system disorders
06/21/2007US20070142229 Agriculture
06/20/2007EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/14/2007WO2007032019A3 Process for preparing valsartan
06/14/2007WO2006078275A3 Ionic liquid energetic materials
06/14/2007US20070135631 Heterocyclic cetp inhibitors
06/13/2007CN1980903A 取代的环状脲衍生物 Substituted cyclic urea derivatives
06/13/2007CN1977837A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
06/13/2007CN1977836A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
06/13/2007CN1321101C New retinoids for the treatment of emphysema
06/12/2007US7230031 Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
06/12/2007US7230022 Substituted fused bicyclic amines as modulators of chemokine receptor activity
06/12/2007US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
06/07/2007WO2007064227A1 Multimeric magentic resonance contrast agents
06/07/2007WO2007063789A1 Novel catechol derivative, pharmaceutical composition containing same, and uses of those
06/07/2007US20070129413 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl) biphenyl derivatives
06/07/2007US20070129349 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester
06/07/2007US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia
06/07/2007CA2629143A1 Multimeric magentic resonance contrast agents
06/07/2007CA2628817A1 Iminopropene compound and use thereof
06/05/2007US7227026 Synthesis of a novel intermediate, 2-(1-trityl-1H-tetrazol-5-yl)phenylboronic acid, by combining 5-phenyl-1H-tetrazole with chlorotriphenylmethane and then reacting with a borate, both in basic solutions; a Suzuki coupling reaction with a protected imidazolephenylboronic acid will give irbesartan
06/05/2007US7226578 Metal complexes that contain perfluoroalkyl, process for their production and their use in NMR diagnosis
05/2007
05/31/2007WO2007060026A1 Urea derivatives useful as calcium receptor modulators
05/31/2007WO2007059908A1 Novel cyclic iminopeptide derivatives and a process for preparing cyclic iminopeptide derivatives
05/31/2007US20070122367 Resorcinol derivatives
05/31/2007CA2630860A1 Urea derivatives useful as calcium receptor modulators
05/30/2007EP1429763B1 NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER
05/30/2007CN1970555A Process for the preparation of angiotensin ii antagonistic compounds
05/29/2007CA2214565C New cryptophycins from synthesis
05/24/2007US20070117987 Process for preparing valsartan
05/23/2007EP1786789A2 Process for preparing substituted tetrazoles from aminotetrazole
05/23/2007EP1786475A2 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri)
05/22/2007US7220777 Lactam derivatives as antagonists for human 11cby receptors
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 97